Nano Holdings, Inc. (TYO:4571)

Japan flag Japan · Delayed Price · Currency is JPY
150.00
+1.00 (0.67%)
Apr 17, 2026, 3:30 PM JST
Market Cap12.06B +16.2%
Revenue (ttm)155.00M +36.0%
Net Income-887.00M
EPS-12.45
Shares Out80.39M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume369,000
Average Volume733,750
Open148.00
Previous Close149.00
Day's Range146.00 - 150.00
52-Week Range124.00 - 254.00
Beta0.44
RSI45.25
Earnings DateMay 12, 2026

About Nano Holdings

Nano Holdings, Inc. researches, develops, produces, and sells pharmaceuticals using micellar nanoparticles technology in Japan. The company’s pipeline products include RUNX1 (mRNA) for the treatment knee osteoarthritis and reduces pain; and NC-6100 PRDM14 (siRNA), which is in phase I clinical trials for the treatment of breast cancer. Its product pipeline also comprises TUG1 (ASO) for glioblastoma multiforme. In addition, it offers cosmetic raw material. The company was formerly known as NANO MRNA Co.,Ltd. and changed its name to Nano Holdings,... [Read more]

Industry Biotechnology
Sector Healthcare
Founded 1996
Employees 20
Stock Exchange Tokyo Stock Exchange
Ticker Symbol 4571
Full Company Profile

Financial Performance

In fiscal year 2025, Nano Holdings's revenue was 108.00 million, a decrease of -20.00% compared to the previous year's 135.00 million. Losses were -835.00 million, 7.05% more than in 2024.

Financial Statements